UbiVac Appoints Walter J. Urba, M.D., Ph.D., to Scientific Advisory Board
Former Providence Cancer Institute CMO and cancer immunotherapy pioneer Dr. Walter Urba joins UbiVac SAB to advance Dark Matter immunotherapies. PORTLAND, OR, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- UbiVac, a clinical-stage …